default author photo

Brett Hanscom

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division

SCHOLARLY PAPERS

2

DOWNLOADS

204

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety of Meningococcal ACWYX Conjugate Vaccine When Coadministered with Routine Childhood Vaccines at 9-Months and 15-Months of Age: A Randomised, Controlled, Phase 3, Non-Inferiority Trial

Number of pages: 41 Posted: 08 Oct 2024
Fatoumata Diallo, Fadima Haidara, Milagritos D. Tapia, Souleymane Diakite, Alfousseny Toure, Youssouf Traore, Awa Traore, Mamoudou Kodio, Clara Dominguez Islas, Fleesie Hubbard, William Hausdorff, Lionel Martellet, Nancy Hosken, Mark Alderson, Dhananjay Kapse, Prasad S. Kulkarni, Kelly Townsend-Payne, Francesca Vanni, Monica M. Farley, Brett Hanscom, Clifton Kelly, Christine M. Posavad, Samba O. Sow, Karen L. Kotloff and Wilbur Chen
Centre pour le Développement des Vaccins (CVD-Mali), Centre pour le Développement des Vaccins (CVD-Mali), - Department of Pediatrics, Centre pour le Développement des Vaccins (CVD-Mali), Centre pour le Développement des Vaccins (CVD-Mali), Centre pour le Développement des Vaccins (CVD-Mali), Centre pour le Développement des Vaccins (CVD-Mali), Centre pour le Développement des Vaccins (CVD-Mali), Fred Hutchinson Cancer Research Center, - Center for Vaccine Development and Global Health, PATH, PATH, PATH, PATH, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, UK Health Security Agency, VisMederi SRL, Emory University - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Government of Mali - Centre pour le Développement des Vaccins, - Department of Pediatrics and University of Maryland School of Medicine - Center for Vaccine Development and Global Health
Downloads 137 (534,155)

Abstract:

Loading...

Meningitis, Vaccine, Phase 3

2.

Estimating the Impact of PrEP Regimens Containing Long-Acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine Among Men Who Have Sex with Men in the United States: Mathematical Modelling for HPTN 083

Number of pages: 19 Posted: 26 May 2022
Kate M. Mitchell, Marie-Claude Boily, Brett Hanscom, Mia Moore, Jeffery Todd, Gabriela Paz-Bailey, Cyprian Wejnert, Albert Y. Liu, Deborah Donnell, Beatriz Grinsztejn, Raphael Landovitz and Dobromir Dimitrov
Imperial College London - Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London - Medical Research Council Centre for Global Infectious Disease Analysis, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Georgia Department of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), San Francisco Department of Health - Bridge HIV, Fred Hutchinson Cancer Research Center, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 67 (899,324)

Abstract:

Loading...

HIV, pre-exposure prophylaxis, long-acting PrEP, injectable PrEP, cabotegravir, Men who have sex with men, MSM, United States, Atlanta, mathematical modelling